Methes Energies International (MEIL) 10-Q 13 Apr 15 2015 Q1 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	3 Months Ended
	Feb. 28, 2015	Apr. 13, 2015
Document And Entity Information
Entity Registrant Name	METHES ENERGIES INTERNATIONAL LTD
Entity Central Index Key	1436549
Document Type	10-Q
Document Period End Date	28-Feb-15
Amendment Flag	FALSE
Current Fiscal Year End Date	-19
Is Entity a Well-known Seasoned Issuer?	No
Is Entity a Voluntary Filer?	No
Is Entity's Reporting Status Current?	Yes
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		11,510,431
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2015

CONDENSED_CONSOLIDATED_BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (USD $)	Feb. 28, 2015	Nov. 30, 2014
Current assets
Cash and cash equivalents	$115,585	$65,649
Accounts receivable, net (notes 12, 13 and 15)	602,073	247,771
Inventories (note 3)	414,767	410,699
Prepaid expenses and deposits	54,252	41,692
Total current assets	1,186,675	765,811
Deposits	20,588	18,891
Property, plant and equipment, net (note 4)	7,741,008	7,845,745
Intangible assets, net	367,760	372,811
Total assets	9,316,031	9,003,258
LIABILITIES AND STOCKHOLDERS' EQUITY
Accounts payable (note 13)	890,088	634,466
Accrued liabilities	202,820	214,240
Customer deposits	132,346	144,640
Payable to related party (note 5)	82,982	81,382
Short-term loan (note 6)	1,079,730	1,180,035
Total current liabilities	2,387,966	2,254,763
Non-current liabilities
Payable to related party (note 7)	797,371	772,270
Term loan (note 8)	1,867,028	1,837,188
Total non-current liabilities	2,664,399	2,609,458
Total liabilities	5,052,365	4,864,221
Stockholders' equity
Preferred stock, $0.001 par value, 10,000,000 shares authorized; 111,822 and 111,822 shares issued and outstanding as at November 30, 2014 and February 28, 2015, respectively (note 10)	112	112
Common stock, $0.001 par value, 75,000,000 shares authorized; 11,510,431 and 11,510,431 shares issued and outstanding at November 30, 2014 and February 28, 2015, respectively (note 10)	11,509	11,509
Additional paid-in capital	26,411,520	26,342,831
Accumulated deficit	-22,159,475	-22,215,415
Total stockholders' equity	4,263,663	4,139,037
Total liabilities and stockholders' equity	$9,316,031	$9,003,258

CONDENSED_CONSOLIDATED_BALANCE1

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Feb. 28, 2015	Nov. 30, 2014
Stockholders' equity
Preferred stock par value	$0.00	$0.00
Preferred stock shares authorized	10,000,000	10,000,000
Preferred stock shares issued	111,822	111,822
Preferred stock shares outstanding	111,822	111,822
Common stock, par value	$0.00	$0.00
Common stock, shares authorized	75,000,000	75,000,000
Common stock, shares issued	11,510,431	11,510,431
Common stock, shares outstanding	11,510,431	11,510,431

CONDENSED_CONSOLIDATED_STATEME

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) (USD $)	3 Months Ended
	Feb. 28, 2015	Feb. 28, 2014
Revenue
Biodiesel sales	$36,638	$309,537
Feedstock sales	0	26,623
Glycerin sales	0	13,197
Government incentives (note 15)	1,637	13,035
Equipment and part sales	0	647
Royalties	2,706	0
Others (note 12)	843,338	15,440
Revenue, Total	884,319	378,479
Cost of goods sold	12,900	292,618
Gross profit	871,419	85,861
Operating expenses
Selling, general and administrative expenses (notes 4, 10 and 11)	753,641	1,465,409
(Loss) income before interest, rental income and taxes	117,778	-1,379,549
Other (expense) income
Interest expense (note 17)	-70,202	-101,892
Rental income	8,364	0
(Loss) income before income taxes	55,940	-1,481,441
Income taxes	0	0
Net (loss) income for the period	$55,940	($1,481,441)
Net (Loss) Income Per Common Share - Basic and Diluted	$0.01	($0.18)
Weighted average number of Common Shares - Basic	11,510,431	8,125,419
Weighted average number of Common Shares - Diluted	11,647,898	8,125,419

CONDENSED_CONSOLIDATED_STATEME1

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (USD $)	Common Stock	Preferred Stock	Additional Paid-In Capital	Accumulated Deficit	Total
Beginning Balance, Amount at Nov. 30, 2013	$7,231	$261	$18,532,803	($15,892,703)	$2,647,592
Beginning Balance, Shares at Nov. 30, 2013	7,231,417	260,782
Issuance of Common Stock units under private placement, Shares	1,081,161
Issuance of Common Stock units under private placement, Amount	1,081		2,161,240		2,162,321
Issuance of common stock under public offering, Shares	2,800,000
Issuance of common stock under public offering, Amount	2,800		5,597,200		5,600,000
Issuance cost - Common stock			-949,358		-949,358
Issuance of common stock units for cash upon conversion of preferred stock units, Shares	148,960	-148,960
Issuance of common stock units for cash upon conversion of preferred stock units, Amount	149	-149
Issuance of common stock upon conversion of dividends on preferred stock, Shares	7,205
Issuance of common stock upon conversion of dividends on preferred stock, Amount	7		16,229	-16,236
Issuance of common stock units for cash, Shares	16,129
Issuance of common stock units for cash, Amount	16		99,984		100,000
Issuance of Common stock for services, Shares	183,871
Issuance of Common stock for services, Amount	184		545,566		545,750
Issuance of common stock units for loan settlement, Shares	34,688
Issuance of common stock units for loan settlement, Amount	34		127,965		127,999
Issuance of common stock upon conversion of placement agent warrants, Shares	7,000
Issuance of common stock upon conversion of placement agent warrants, Amount	7		13,993		14,000
Stock based compensation			197,209		197,209
Net income/ loss for the period				-6,306,476	-6,306,476
Ending Balance, Amount at Nov. 30, 2014	11,509	112	26,342,831	-22,215,415	4,139,037
Ending Balance, Shares at Nov. 30, 2014	11,510,431	111,822
Stock based compensation			1,009		1,009
Issuance of common stock warrants			67,680		67,680
Net income/ loss for the period				55,940	55,940
Ending Balance, Amount at Feb. 28, 2015	$11,509	$112	$26,411,520	($22,159,475)	$4,263,663
Ending Balance, Shares at Feb. 28, 2015	11,510,431	111,822

CONDENSED_CONSOLIDATED_STATEME2

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (USD $)	3 Months Ended
	Feb. 28, 2015	Feb. 28, 2014
Cash flow from operating activities:
Net (loss) income for the period	$55,940	($1,481,441)
Adjustments to reconcile net (loss) income to net cash used in operations
Depreciation and amortization	109,788	110,829
Stock-based compensation	1,009	48,898
Unrealized foreign exchange gain	-100,305	-79,786
Deferred financing fees amortization		17,798
Accrued interest	44,901	46,003
Bad debts (recovery)	-35,662	235,224
Issuance of common stock warrants to a lender	67,680
Changes in operating assets and liabilities:
Accounts receivable	-318,640	1,012,762
Inventories	-4,068	265,599
Prepaid expenses and deposits	-14,257	28,217
Accounts payable	255,624	-922,074
Accrued liabilities	-11,420	19,798
Customer deposits	-12,294	919
Net cash (used in) provided by operating activities	38,296	-697,254
Cash flows from investing activities:
Additions to property, plant and equipment		-51,821
Net cash used in investing activities		51,821
Cash flows from financing activities:
Repayment of credit facility		-1,019,513
Repayments of short term loans		-153,781
Advances from related parties and others	11,640	172,000
Repayments to related parties and others		-33,835
Issuance of common stock/units under private placement		2,162,231
Issuance costs - common stock units under private placement		-360,277
Issuance of common stock/units for cash		100,000
Net cash provided by financing activities	11,640	866,825
NET INCREASE IN CASH AND CASH EQUIVALENTS	49,936	117,750
Cash and cash equivalents, beginning of period	65,649	174,084
CASH AND CASH EQUIVALENTS, END OF PERIOD	115,585	291,834
Supplemental disclosures of cash flow information
Interest paid	22,419	42,727
Common shares issued as repayment of loan		$128,000

1_NATURE_OF_THE_BUSINESS_AND_G

1. NATURE OF THE BUSINESS AND GOING CONCERN	3 Months Ended
	Feb. 28, 2015
Accounting Policies [Abstract]
1. NATURE OF THE BUSINESS AND GOING CONCERN	Methes Energies International Ltd. (the “Company”, or “Methes”) was incorporated on June 27, 2007 in the State of Nevada. Methes, through its operations in Canada and the United States, is a biodiesel processing equipment provider and a biodiesel producer. The Company has developed biodiesel processing equipment to produce biodiesel from recycled oils. The Company, through its wholly-owned subsidiary Methes Energies Canada Inc. (“Methes Canada”), owns two biodiesel manufacturing facilities; one is located in Mississauga, Ontario with a nameplate production capacity of 1.3 million gallons per year (mgy) (see note 19 - Subsequent Event), and the second facility is capable of producing 13.0 mgy of biodiesel located in Sombra, Ontario. In addition to Methes Canada, Methes Energies USA Ltd. ("Methes USA") was incorporated as the wholly-owned subsidiary of the Company on June 27, 2007. All references in this Form 10-Q to “Company,” “Methes,” “we,” “us,” or “our” refer to Methes Energies International Ltd. and its wholly owned subsidiaries Methes Canada and Methes USA unless the context otherwise indicates.
	As at February 28, 2015, due in large part to the funds spent to develop and build its Sombra facility as well as minimal sales of biodiesel, the Company had an accumulated deficit of $22,159,477 and significant losses and negative cash flows from operations in prior periods. In addition, as at February 28, 2015, the Company had working capital deficiency of $1,201,291. During the three months ended February 28, 2015, the Company earned income of $55,940, mainly attributable to its negotiated share of the Blenders Tax Credit (“BTC”), and had positive cash flows from operations of $38,296. The Sombra facility is now idle because of a lack of demand for biodiesel at favorable prices. When put back into commercial production, the Company anticipates that its Sombra facility will generate positive cash flow from operations and will operate profitably once a sufficient level of commercial operations is achieved. However, there is uncertainty that this will occur in the near future so as to enable the Company to meet its obligations as they come due. As a result, there is substantial doubt regarding the Company’s ability to continue as a going concern. The Company may require additional financing to fund its operations, which may not be available at acceptable terms or at all. Subsequent to the quarter-end, the Company entered into an agreement for the sale of the Denami 600 biodiesel processor located at its Mississauga facility and a PP-MEC pre-treatment system as described in note 19. Additionally, the Company plans on utilizing the existing feedstock credit facility once its Sombra facility recommences commercial operations, and finalizing the terms of the Technology Licensing Agreement as described in note 18.
	The condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of the recorded asset amounts or the amounts and classification of the recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.
	The condensed consolidated financial statements have been prepared by the Company without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America (GAAP) have been condensed or omitted as permitted by such rules and regulations. All adjustments, consisting of normal recurring adjustments, have been included. Management believes that the disclosures are adequate to present fairly the financial position, results of operations and cash flows at the dates and for the periods presented. It is suggested that these interim financial statements be read in conjunction with the consolidated financial statements and the notes thereto appearing in the Company’s latest annual report on Form 10-K. Results for interim periods are not necessarily indicative of those to be expected for the full fiscal year.

2_SUMMARY_OF_SIGNIFICANT_ACCOU

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	3 Months Ended
	Feb. 28, 2015
Accounting Policies [Abstract]
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	Basis of Consolidation
	The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries Methes Canada and Methes USA. All significant inter-company transactions and balances have been eliminated.
	Shipping and Handling Costs
	The Company accounts for shipping and handling fees in accordance with FASB ASC 705 "Cost of Sales and Services". Shipping and handling costs for the three months ended February 28, 2014 and February 28, 2015 were $15,570 and $17,881, respectively. Costs related to raw materials purchased, are included in inventory or cost of goods sold, as appropriate. While amounts charged to customers for shipping product are included in revenues, the related outbound freight costs are included in expenses as incurred.
	Income Taxes and Uncertain Tax Positions
	The Company accounts for income taxes under ASC 740 Accounting for Income Taxes. Under ASC 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the periods in which those temporary differences are expected to be recovered or settled. Under ASC 740, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. ASC 740-10-05, Accounting for Uncertainty in Income Taxes, prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return.
	For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities.
	The amount recognized is measured as the largest amount of benefit that is greater than 50 percent likely of being realized upon ultimate settlement. Potential tax benefits from net operating losses and foreign tax credit carry forwards are not recognized by the Company until their realization is more likely than not. The Company assesses the validity of conclusions regarding uncertain tax positions on a quarterly basis to determine if facts or circumstances have arisen that might cause the Company to change their judgment regarding the likelihood of a tax position's sustainability under audit. The Company has determined that there were no material uncertain tax positions as at November 30, 2014 and February 28, 2015.
	Per Share Data
	Basic earnings per share ("EPS") is determined by dividing net earnings available to common stockholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. In computing diluted EPS, the average number of shares of Common Stock outstanding is increased by Common Stock options and warrants outstanding if the exercise prices were lower than the average market price of Common Stocks using the treasury stock method. Diluted earnings per share exclude all potentially dilutive shares if their effect is anti-dilutive. Potentially dilutive shares include 3,923,149 warrants, 365,931 Common Stock options and 260,782 shares of Preferred Stock issued and outstanding as at February 28, 2014 and 4,073,149 warrants, 426,819 Common Stock options and 111,822 shares of Preferred Stock issued and outstanding as at February 28, 2015. All outstanding warrants, preferred shares and options have an anti-dilutive effect on the loss per share and are therefore excluded from the determination of the diluted loss per share calculation for the three months ended February 28, 2014.
	New Accounting Pronouncements
	On May 28, 2014, the FASB issued a new financial accounting standard on revenue from contracts with customers, Update No. 2014-09, Revenue from Contracts with Customers (Topic 606). The standard outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance. The accounting standard is effective for annual reporting periods (including interim reporting periods within those periods) beginning after December 15, 2017. Early adoption is not permitted. The Company is currently evaluating the impact of this accounting standard.
	On August 27, 2014, the FASB issued a new financial accounting standard on going concern, Update 2014-15, Presentation of Financial Statements - Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern. The standard provides guidance about management’s responsibility to evaluate whether there is substantial doubt about the organization’s ability to continue as a going concern. The amendments in this Update apply to all companies. They become effective in the annual period ending after December 15, 2016, with early application permitted. The Company is currently evaluating the impact of this accounting standard.
	On April 7, 2015, the FASB issued Accounting Standards Update (ASU) No. 2015-03, Interest - Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs. The amendments in this ASU require that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts and the accounting for debt issue costs under IFRS. The recognition and measurement guidance for debt issuance costs are not affected by the amendments in this ASU. The amendments in this Update apply to all companies. They become effective for public business entities in the annual period ending after December 15, 2015, and interim periods within those fiscal years, with early application permitted. The Company is currently evaluating the impact of this accounting standard.
	All other recent pronouncements issued by the FASB or other authoritative standards groups with future effective dates are either not applicable or are not expected to be significant to the condensed consolidated financial statements of the Company.

3_INVENTORIES

3. INVENTORIES	3 Months Ended
	Feb. 28, 2015
Inventory Disclosure [Abstract]
3. INVENTORIES	Inventories consisted of the following:
		As at		As at
		November 30,		February 28,
		2014		2015
	Raw materials	$	199,669	$	207,217
	Finished goods		199,664		196,184
	Equipment		11,366		11,366
		$	410,699	$	414,767

4_PROPERTY_PLANT_AND_EQUIPMENT

4. PROPERTY, PLANT AND EQUIPMENT	3 Months Ended
	Feb. 28, 2015
Property, Plant and Equipment [Abstract]
4. PROPERTY, PLANT AND EQUIPMENT		As at February 28, 2015						As at
								November 30,
								2014
		Cost		Accumulated		Net Book		Net Book
				Depreciation		Value		Value
	Sombra site:
	Land	$	409,134	$	—	$	409,134	$	409,134
	Building		2,944,356		333,919		2,610,437		2,628,838
	Equipment		775,865		519,479		256,386		283,201
	Equipment - Denami 3000		4,254,995		401,588		3,853,407		3,895,956
	Computer equipment		11,835		11,470		365		937
	Vehicle		11,622		1,744		9,878		10,169
	Mississauga site:
	Computer equipment		23,464		23,464		—		1
	Leasehold improvements		102,201		68,600		33,601		36,200
	Equipment and fixtures		255,463		210,051		45,412		51,721
	Equipment - Denami 600 (note 19)		720,042		197,654		522,388		529,588
		$	9,508,977	$	1,767,969	$	7,741,008	$	7,845,745
	Total depreciation expense included in selling, general and administrative expenses in the unaudited consolidated statements of operations related to property, plant and equipment for the three months ended February 28, 2014 and February 28, 2015 was $105,778 and $104,741, respectively.

5_PAYABLE_TO_RELATED_PARTY

5. PAYABLE TO RELATED PARTY	3 Months Ended
	Feb. 28, 2015
Related Party Transactions [Abstract]
5. PAYABLE TO RELATED PARTY	Payable to related parties is comprised of the following:
		As at		As at
		November 30,		February 28,
		2014		2015
	Michel G. Laporte (stockholder and Director)	$	81,382	$	82,982
	Interest expense incurred during the three months ended February 28, 2015 was $1,600 (three months ended February 28, 2014 - $nil).

6_SHORTTERM_LOAN

6. SHORT-TERM LOAN	3 Months Ended
	Feb. 28, 2015
Debt Disclosure [Abstract]
6. SHORT TERM LOAN		As at		Interest Accrued		Repayments		Foreign Exchange Adjustments		As at
		November 30,								February 28,
		2014								2015
	Term loan (July 2013)	$	1,180,035	$	—	$	—	$	-100,305	$	1,079,730
	Term loan (July 2013)
	On July 12, 2013, Methes Canada entered into a term loan facility agreement with a lender (the “Agreement”) pursuant to which Methes Canada is able to borrow up to $1,279,680 (CDN$1,600,000) for a term of 12 months at an interest rate of 12% per annum (the “July 2013 Facility”). Under the terms of the Agreement, interest is payable monthly and outstanding principal is due at maturity. Outstanding principal would be prepayable after six months upon 30 days’ notice and payment of a penalty equal to one-month's interest. The July 2013 Facility is collateralized by a security agreement from Methes Canada on certain of its assets except for accounts receivable and inventory and a first collateral mortgage on its real property located at Sombra, Ontario.  The July 2013 Facility prohibits payment of debt owed by the Company to certain of its stockholders, a director and an unrelated Corporation (see notes 5, 7 and 8) during the life of the facility and contains other customary debt covenants.
	Interest expense incurred during the three months ended February 28, 2015 was $22,158 (February 28, 2014 - $43,718).

7_PAYABLE_TO_RELATED_PARTY_ONE

7. PAYABLE TO RELATED PARTY ONE	3 Months Ended
	Feb. 28, 2015
Notes to Financial Statements
7. PAYABLE TO RELATED PARTY	Payable to related party includes promissory notes due to Michel Laporte, the chief executive officer, a stockholder and director of the Company.  The promissory notes bear interest at 8% per annum, are unsecured and payable on demand. Mr. Laporte has agreed not to demand payment until April 1, 2016.
	The principal amount outstanding as at February 28, 2015 was an aggregate of $674,640 and the total accrued interest was $122,731 (as at November 30, 2014, principal of $663,000 and interest of $109,270).
	Interest expense incurred during the three months ended February 28, 2015 was $13,461 (three months ended February 28, 2014 - $13,260.)

8_TERM_LOAN

8. TERM LOAN	3 Months Ended
	Feb. 28, 2015
Debt Disclosure [Abstract]
8. TERM LOAN	Term loan includes promissory notes due to an unrelated Corporation.  The promissory notes bear interest at 8% per annum, are unsecured and payable on demand. The unrelated Corporation has agreed not to demand payment until April 1, 2016.
	The principal amount outstanding as at February 28, 2015 was an aggregate of $1,492,000 and the total accrued interest was $375,028 (as at November 30, 2014, principal of $1,492,000 and total interest of $345,188).
	Interest expense incurred during the three months ended February 28, 2015 was $29,840 (three months ended February 28, 2014 - $26,858).

9_CREDIT_FACILITY

9. CREDIT FACILITY	3 Months Ended
	Feb. 28, 2015
Notes to Financial Statements
9. CREDIT FACILITY	On August 28, 2014, the Company entered into a feedstock credit facility with a major provider of credit to the renewable fuels industry (the “Lender”), which will provide the Company all the feedstock required to run at full capacity and allow the Company to fulfill future orders for biodiesel that it receives from its customers that have been approved by the credit department of the Lender.  The Company had also agreed to a biodiesel sales contract subject to the Lender’s approval and subject to a tripartite payment and Assignment Agreement.  The facility bears interest at 5% per annum. The facility will initiate upon payment by the Company of a $400,000 deposit that is required as collateral for the feedstock. As at February 28, 2015 the deposit had not been made.
	During the 2014 fiscal year, the Company began entering into certain derivative contracts with the Lender to hedge its exposure to price risk related to feedstock oil. The Company recorded realized losses during the three months ended February 28, 2015 of $nil (February 28, 2014 - $ nil) as part of cost of goods sold upon expiry of these contracts during the fiscal year.  As at February 28, 2015 and November 30, 2014, no derivative futures contracts or call options were outstanding.

10_STOCKHOLDERS_EQUITY

10. STOCKHOLDERS' EQUITY	3 Months Ended
	Feb. 28, 2015
Equity [Abstract]
10. STOCKHOLDERS' EQUITY	COMMON STOCK
	The Company is authorized to issue 75,000,000 shares of Common Stock with a par value of $0.001 and had 11,510,431 shares of Common Stock issued and outstanding as of November 30, 2014 and February 28, 2015.
			No. of Shares			Price per Share
	Common Stock
	Balance as at November 30, 2013			7,231,417
	Issuance of shares under private placement			1,081,161		$	2
	Issuance of shares under public offering			2,800,000		$	2
	Issuance of shares upon conversion of Preferred Stocks units			148,960		$	2.26
	Issuance of shares upon conversion of accrued dividends on Preferred Stocks units			7,205		$	2.26
	Issuance of shares for cash			16,129		See below
	Issuance of shares for services			183,871		See below
	Issuance of shares for loan settlement			34,688		$	3.69
	Issuance of shares upon conversion of Placement Agent Warrant			7,000			2
	Balance as at November 30, 2014 and February 28, 2015			11,510,431
	During the year ended November 30, 2014, the following issuances were completed:
	Issuance of Common Stock units under Private Placement
	During the month of December 2013 the Company issued a total of 1,081,161 units (each a “Unit”) to accredited investors at a price of $2.00 per Unit under a private placement and raised net proceeds of approximately $1.87 million, after deducting the sales commission and fees (the “December 2013 Private Placement”). Each Unit consists of one share of Common Stock and one five year Common Stock Warrant to purchase one share of Common Stock at an exercise price of $4.00 per share (“Common Stock Warrant”). (see Stock Warrant Table below).
	In connection with the December 2013 Private Placement, the Company issued compensatory warrants (the “Placement Agent Warrant”) to the Placement Agents for the offering exercisable for an aggregate of 108,116 Units.  Each of these warrants is exercisable to acquire a Unit at an exercise price of $2.00 per Unit.  The fair value of these warrants at the grant date was $257,553.  This amount was estimated using the Black-Scholes option pricing model with an expected life of 5 years, risk free interest rates between 1.66% and 1.74%, a dividend yield of 0%, and an expected volatility of 75%. (see Stock Warrant Table below).
	Issuance of Common Stocks upon conversion of Preferred Stocks units and accrued dividends
	i)	Series A-2 Preferred Stock Conversions
	On March 13, 2014, two holders of our Series A-2 Convertible Preferred Stock (“Series A-2 Preferred”) converted 20,876 shares of outstanding Series A-2 Preferred with an aggregate stated value of approximately $49,139 (including accrued dividends of $1,750). The Series A-2 Preferred was converted into 21,648 shares of Common Stock at a price of $2.27 per share, which included the issuance of 772 shares of Common Stock attributable to the conversion of the accrued dividends.
	On May 9, 2014, a holder of our Series A-2 Preferred converted 10,438 shares of outstanding Series A-2 Preferred with an aggregate stated value of approximately $26,250 (including accrued dividends of $1,250). The Series A-2 Preferred was converted into 10,989 shares of Common Stock at a price of $2.27 per share, which included the issuance of 551 shares of Common Stock attributable to the conversion of the accrued dividends.
	ii)	Series A-1 Preferred Stock Conversions
	On March 17, 2014, two holders of our Series A-1 Convertible Preferred Stock (“Series A-1 Preferred”) converted 117,646 shares of outstanding Series A-1 Preferred with an aggregate stated value of approximately $293,235 (including accrued dividends of $13,235). The Series A-1 Preferred was converted into 123,528 shares of Common Stock at a price of $2.25 per share, which included the issuance of 5,882 shares of Common Stock attributable to the conversion of the accrued dividends.
	Issuance of Common Stocks under Public Offering
	On May 27, 2014, the Company closed an underwritten public offering of 2,500,000 shares of Common Stock and raised net proceeds of $4.5 million, after deducting Underwriter’s fees and estimated offering expenses. Under the terms of the Underwriting Agreement, the Underwriter had an option through June 26, 2014, to purchase up to an additional 375,000 shares of Common Stock under the same terms as the public offering to cover over-allotments (the “Over-Allotment Option”), if any.
	On May 28, 2014, the Underwriter partially exercised the Over-Allotment Option for 300,000 shares of Common Stock raising approximately $550,000 of additional net proceeds for the Company.
	Issuance of Common Stock for cash and services rendered
	On January 3, 2014, the Company issued 25,000 shares of Common Stock in the second installment quarterly payment of consulting fees for services to be rendered by a consultant for over a year which were valued at $87,250, based on the closing market price of $3.49 per share on the day of issuance.  On May 1, 2014, the Company issued 25,000 shares of Common Stock in the third quarterly installment payment of consulting fees for services to be rendered by the consultant which were valued at $61,250, based on the closing market price of $2.45 per share on the date of issuance. On August 1, 2014, the Company issued 25,000 shares of Common Stock in the final quarterly installment payment of consulting fees for services to be rendered by the consultant which were valued at $42,500, based on the closing market price of $1.70 per share on the date of issuance.
	On January 10, 2014, the Company sold 50,000 Units to an accredited investor in a private placement for a purchase price of $125,000 (or $2.50 per Unit) of which $100,000 was paid in cash and $25,000 was settled through services rendered to the Company, which was included in the selling, general and administrative expenses. The aggregate fair value of the Units sold in this offering was $310,000 (or $6.20 per Unit), based on the closing market price of $3.58 per share of Common Stock on the day of issuance, and the fair value of the Common Stock Warrants of $2.62 per warrant.  The Common Stocks allocated to cash portion was 16,129 Common Stocks ($100,000/$310,000 x 50,000 units) and the services portion allocated is 33,871 Common Stocks.  The fair value of the Common Stock Warrants was estimated using the Black-Scholes option pricing model with an expected life of 5 years, risk free interest rates of 1.64%, a dividend yield of 0%, and an expected volatility of 100%.  The excess of the estimated fair value over the purchase price in the amount of $185,000 is included in the selling, general and administrative expenses. (see Stock Warrant Table below).
	On January 28, 2014, the Company issued 25,000 shares of Common Stock in payment of consulting fees for services to be rendered by a consulting corporation for a term of six months.  These shares of Common Stock were valued at $88,750, based on the closing market price of $3.55 per share on the date of issuance.
	On November 20, 2014, the company issued 50,000 shares of Common Stock for services rendered by a consultant which were valued at $56,000, based on the closing market price of $1.12 per share on date of issuance.
	Issuance of Common Stock for loan settlement
	On January 17, 2014, the Company issued 34,688 shares of Common Stock to a note holder at $3.69 per share of Common Stock upon conversion of $128,000 of a note payable by the Company. The note was repaid in full during the year ended November 30, 2014.
	Issuance of Common Stocks upon conversion of Placement Agent Warrants
	On May 9 and 19, 2014, two holders of Placement Agent Warrants exercised their warrants for an aggregate of 7,000 Units at a price of $2.00 per Unit or an aggregate stated value of $14,000, which included 7,000 shares of Common Stock and 7,000 Warrants (each at an exercise price of $4.00).
	During the three months ended February 28, 2015, the following issuance was completed:
	Issuance of Common Stock Warrants to a lender
	On December 18, 2014, the Company issued a 5-year common stock warrant exercisable for up to 150,000 shares at a price of $0.95 per share to a lender (see note 6). The fair value of this warrant was estimated using the Black-Scholes option pricing model with an expected life of 5 years, risk free interest rates of 1.68%, a dividend yield of 0%, and an expected volatility of 95%.  The estimated fair value of $67,680 is included in the selling, general and administrative expenses. (see Stock Warrant Table below).
	PREFERRED STOCK
	The Company is also authorized to issue up to 10,000,000 shares of preferred stock with a par value of $0.001 and had 111,822 and 111,822 shares of preferred stock issued or outstanding as of November 30, 2014 and February 28, 2015.
	As at February 28, 2015, total accumulated dividends are $48,548 that have not been declared or accrued (November 30, 2014 -  $23,004).
	STOCK WARRANT TABLE:
			Grant Date		Exercise Period	No of Warrants		Exercise Price per share		Fair Value of Broker Warrants
	Balance as at November 30, 2013						2,678,872
	Common Stock Warrants issued – Private Placement		Dec. 20, 2013		5 years from grant date		1,081,161	$	4
	Placement Agent Warrant – Private Placement		Dec. 20 2013		5 years from grant date		108,116	$	2	$	257,553
	Placement Agent Warrant – Private Placement (November 27, 2013)		Dec. 20 2013		5 years from grant date		5,000	$	2	$	6,403
	Common Stock Warrant issued-accredited investor		Jan. 10, 2014		5 years from grant date		50,000	$	4
	Placement Agent Warrant exercise						-7,000	$	2
	Common Stock Warrant issued upon exercise of Placement Agent Warrant		May 9 and 14, 2014		Dec. 20, 2018		7,000	$	4
	Balance as at November 30, 2014						3,923,149
	Common Stock Warrant issued (note 6)		18-Dec-14		5 years from grant date		150,000	$	0.95
	Balance as at February 28, 2015						4,073,149

11_STOCKBASED_COMPENSATION

11. STOCK-BASED COMPENSATION	3 Months Ended
	Feb. 28, 2015
Equity [Abstract]
11. STOCK-BASED COMPENSATION	2008 Option Plan:
	The Company's Amended and Restated the 2008 Directors, Officers and Employees Stock Option Plan, which was originally approved by the stockholders at the annual general meeting of the Company held on December 5, 2007, and subsequently amended by the stockholders on July 23, 2008. This plan was established to enable the Company to attract and retain the services of highly qualified and experienced directors, officers, employees and consultants and to give such persons an interest in the success of the Company and its subsidiaries. The total number of shares currently authorized under the plan is 391,134. The options and awards will be granted at the discretion of the Board of Directors. Options issued under the plan that are deemed to be incentive stock options will be priced at not less than 100% of the fair market value of the common shares at the date of the grant, subject to certain limitations for 10 percent stockholders. The fair value of each option granted was estimated at the time of grant using the Black-Scholes option pricing model. There were no options granted during the three months ended February 28, 2014 and 2015.
	All the grants vest quarterly over a two year period and expire on the tenth anniversary of the grant date. The following table summarizes the stock option activities of the Company.
		Number of options
	Outstanding as of November 30, 2013 and February 28, 2014		365,931
	Granted		—
	Exercised		—
	Cancelled/forfeited		-33,897
	Outstanding as of November 30, 2014		332,034
	Granted		—
	Exercised		—
	Cancelled/forfeited		-5,215
	Outstanding as of February 28, 2015		326,819
	The stock-based compensation for the three months ended February 28, 2015 was $1,009 (three months ended February 28, 2014 - $4,872). The Company recorded this in selling, general and administrative expenses with the corresponding credit to additional paid-in capital.
	As of November 30, 2014 the Company has a total of 332,034 options outstanding to purchase Common Stock held by employees, directors and advisory board members, of which 328,284 are vested and exercisable. All of these outstanding stock options have an exercise price above the average market price. As of November 30, 2014, the total fair value of the options granted to employees at the respective grant dates was $1,172,498, of which the unrecognized portion of $1,901 related to the unvested shares associated with these stock option grants will be recognized over a period of one year.
	As of February 28, 2015 the Company has a total of 326,819 options outstanding to purchase Common Stock held by employees, directors and advisory board members, of which 324,319 are vested and exercisable. All of these outstanding stock options have an exercise price above the average market price. As of February 28, 2015, the total fair value of the options granted to employees at the respective grant dates was $1,136,616, of which the unrecognized portion of $892 related to the unvested shares associated with these stock option grants will be recognized over a period of 9 months.
	2012 Option Plan:
	Under the Company’s 2012 Directors, Officers and Employees Stock Option Plan (the “2012 Plan”), the Company granted a total of 100,000 options to purchase Common Stock to its four independent directors and chief financial officer on April 2, 2013.  The total number of shares currently authorized under the plan is 400,000.  The options and awards will be granted at the discretion of the Board. Options issued under this plan that are deemed to be incentive stock options will be priced at not less than 100 percent of the fair market value of the shares of Common Stock underlying the options at the date of the grant, subject to certain limitations for 10 percent stockholders. The fair value of each option granted was estimated at the time of grant using the Black-Scholes option pricing model.
	All the options granted under the 2012 Plan, vest yearly at the rate of one-third per year, starting on the first year anniversary of the grant date and expire on the fifth anniversary of the grant date. On August 5, 2014, vesting period was amended and all the options are fully vested and exercisable.  The following table summarizes the stock option activities of the Company.
	Outstanding as at November 30, 2013 and February 28, 2014		100,000
	Granted		—
	Exercised		—
	Cancelled/forfeited		—
	Outstanding as of November 30, 2014 and February 28, 2015		100,000
	The share-based compensation for the three months ended February 28, 2015 was $nil (three months ended February 28, 2014 - $44,026). The Company recorded this in selling, general and administrative expenses with the corresponding credit to additional paid-in capital.
	As of February 28, 2015 the Company has granted options to purchase a total of 100,000 shares of Common Stock at an exercise price of $3.94 per share, to its four independent directors and chief financial officer, all of which are currently outstanding and are vested and exercisable. All of these outstanding stock options have an exercise price equal to the fair market price on the date of grant. As of February 28, 2015, the total fair value of the options granted to the independent directors and chief financial officer at the respective grant dates was $292,174, all of which has been fully recognized as they are fully vested.

12_OTHER_REVENUE

12. OTHER REVENUE	3 Months Ended
	Feb. 28, 2015
Other Revenue
12. OTHER REVENUE	In the quarter ended February 28, 2015, the Company recognized $843,338 representing its negotiated share of the Blenders Tax Credit (“BTC”) on applicable invoices issued to customers during fiscal 2014. The accounts receivable as at February 28, 2015 include $513,839 relating to the BTC.

13_FAIR_VALUE_MEASUREMENTS_CON

13. FAIR VALUE MEASUREMENTS, CONCENTRATIONS AND RISK	3 Months Ended
	Feb. 28, 2015
Fair Value Disclosures [Abstract]
13. FAIR VALUE MEASUREMENTS, CONCENTRATIONS AND RISK	a) The Company's cash and cash equivalents, which are carried at fair values, are classified as a level 1 financial instrument at November 30, 2014 and February 28, 2015.
	b) The Company is exposed to the following concentrations of risk:
	Major Customers
	Two major customers comprised 69% and 18% of total revenue for the three months ended February 28, 2015 (three months ended February 28, 2014 - two major customers comprised 71% and 9% of total revenue).
	As at February 28, 2015, the accounts receivable balance from two major customers was $280,541 and $185,486, respectively. (November 30, 2014: $24,306 and $24,194).
	Major Vendors
	The Company has an exclusive agreement to manufacture biodiesel processor equipment with a third party equipment manufacturer. During the three months ended February 28, 2015, the Company made purchases of $nil (three months ended February 28, 2014 - $nil) from this equipment manufacturer. As of November 30, 2014 and February 28, 2015, the Company had accounts payable of $6,837 and $nil owing to this equipment manufacturer, respectively.
	The Company’s purchases of feedstock oil and biodiesel from third parties for the three months ended February 28, 2015 were $nil (three months ended February 28, 2014 - $nil).
	As at November 30, 2014, the accounts payable balance to two major vendors were $nil, and $6,398.
	As at February 28, 2015, the accounts payable balance from two major vendors were $nil and $nil.
	Economic and Political Risks
	The Company faces a number of risks and challenges as a result of having primary operations and marketing in Canada and sales in the United States.  Changing political climates in Canada and the United States could have a significant effect on the Company’s business.
	c) The Company's financial instruments are exposed to certain financial risks, including credit risk, currency risk and liquidity risk.
	Credit Risk
	Credit risk is the risk of an unexpected loss if a customer or third party to a financial instrument fails to meet its contractual obligations, and arises principally from the Company's cash and cash equivalents and trade accounts receivable. The Company places its cash and cash equivalents with institutions of high creditworthiness. The carrying value of the financial assets represents the maximum credit exposure.
	The Company minimizes credit risk by routinely reviewing the credit risk of the counterparty to the arrangement and has maintained an allowance for doubtful accounts of $30,000 related to credit risk as at February 28, 2015 (three months ended February 28, 2014 of $30,000), which is considered adequate.
	Currency Risk
	The Company is exposed to the financial risk related to the fluctuation of foreign exchange rates. The Company's functional currency is U.S. dollars. A significant change in the currency exchange rates between the U.S. dollar relative to the Canadian dollar could have an effect on the Company's results of operations, financial position and cash flows. The Company has not entered into any derivative financial instruments to manage exposures to currency fluctuations.
	Included in selling, general and administrative expenses is a foreign currency gain for the three months ended February 28, 2015 of $126,800 (three months ended February 28, 2014 - gain of $79,786).
	The Canadian dollar balances and exchange differences are as follows:
		CDN$		USD$ Historical		USD –February 28, 2015
	Note 6: Term loan (“July 2013”) - Principal	$	1,350,000	$	1,299,915	$	1,079,730
	Note 15: Canadian Incentive - Sombra facility - Total Incentive per Agreement		5,000,000	NA			3,999,000
	Liquidity Risk
	Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they fall due.  The Company has a working capital deficiency, and is exposed to this risk mainly in respect of its accounts payable and accrued liabilities and short-term loans (see note 1).

14_COMMITMENTS

14. COMMITMENTS	3 Months Ended
	Feb. 28, 2015
Commitments and Contingencies Disclosure [Abstract]
14. COMMITMENTS	Building Leases:
	Methes Canada is a party to a lease agreement for the Mississauga facility and to a sublease agreement for a unit adjacent to its Mississauga facility. On September 28, 2012, the Company re-negotiated and renewed a combined five year lease term for both of these facilities starting from January 1, 2013 to December 31, 2017. The renewed lease term provided for a two month rent free period in 2013.
	As at February 28, 2015, Methes Canada must pay in addition to other amounts, such as its pro rata share of taxes, the following amounts over the term of the lease:
			Annual
			Minimum Rent
	2015		$	86,953
	2016		$	115,937
	2017		$	115,937
	2018		$	9,661
	Railroad Car Leases:
	As at February 28, 2015, the Company is a party to the following lease agreements for railcars at its Sombra facility:
		Start Date		End Date	Term
	Four railcars at $3,100 per month	1-Aug-13		31-Jul-18	60 months
	Four railcars at $3,100 per month	1-Apr-13		31-Mar-18	60 months
	Four railcars at $ 3,600 per month	1-Jul-13		30-Jun-18	60 months
	Four railcars at $3,140  per month	1-Dec-11		30-Nov-16	60 months
	One railcar at $575 per month	1-Jan-12		31-Dec-16	60 months
	One railcar at $575 per month	1-May-12		30-Jun-15	36 months
			Annual
			Minimum Rent
	2015		$	123,935
	2016		$	162,180
	2017		$	118,175
	2018		$	62,400

15_CONTRIBUTION_AGREEMENTS_WIT

15. CONTRIBUTION AGREEMENTS WITH MINISTER OF NATURAL RESOURCES OF CANADA	3 Months Ended
	Feb. 28, 2015
Notes to Financial Statements
15. CONTRIBUTION AGREEMENTS WITH MINISTER OF NATURAL RESOURCES OF CANADA	Mississauga Facility:
	In 2009, the Company entered into a Non-Refundable Contribution Agreement with the Minister of Natural Resources of Canada for the Mississauga facility under the ecoENERGY for Biofuels program. Under this agreement, as amended, the Company was eligible to receive up to $4,728,881 (CDN$5,410,000) in the years from 2009 to 2016 from the Canadian government in biodiesel production incentives when biodiesel is produced and sold. The contribution from the Canadian Government is non-refundable by the Company. On December 24, 2014 the Natural Resources of Canada terminated the Contribution Agreement for the Mississauga facility as it was not being used to meet the minimum production requirement.
	Since entering into the program to February 28, 2015, the Company has claimed and received total incentives of $1,458,286.
	Sombra Facility:
	In 2010, the Company applied for an incentive under the ecoENERGY for Biofuels program for its Sombra facility and was approved by the Canadian government. The final Contribution Agreement with the Minister of Natural Resources of Canada for the Sombra facility under the ecoENERGY for Biofuels program was signed by the Company and the Canadian Government on December 6, 2011. Under this agreement, as amended, the Company may receive a total of up to $3,999,000 (CDN$5,000,000)  during program years 2015-2016 and 2016-2017, as well as $0.24 (CDN$0.30) per gallon for the remainder of program year 2014-2015, ending March 31, 2015, from the Canadian government in biodiesel production incentives when biodiesel is produced and sold. The contribution from the Canadian Government is non-refundable by the Company.
	For the three months ended February 28, 2015, the Company claimed incentives of $1,637 (three months ended February 28, 2014 - $13,035). Since entering into the program to February 28, 2015, the Company has claimed total incentives of $904,473 and has received a total of $902,836.
	Included in accounts receivable as at November 30, 2014 and February 28, 2015, is an amount receivable of $147,776 and $1,637, respectively, due from the Minister of Natural Resources of Canada.

16_SEGMENT_INFORMATION

16. SEGMENT INFORMATION	3 Months Ended
	Feb. 28, 2015
Segment Reporting [Abstract]
16. SEGMENT INFORMATION	The Company reports a single operating segment, being a producer and seller of biodiesel fuel and biodiesel processing equipment.
	Geographic segments:
	The Company's assets and operating facilities, other than cash and cash equivalents balances of $4,943 at November 30, 2014 and $24,314 at February 28, 2015, are all located in Canada. The Company services the majority of its customers in the United States. The Company derives its revenue geographically as follows:
		Three Months Ended February 28,		Three Months Ended February 28,
		2014		2015
	Revenue
	United States	$	288,978	$	843,303
	Canada		89,501		41,016
		$	378,479	$	884,319

17_INTEREST_EXPENSE

17. INTEREST EXPENSE	3 Months Ended
	Feb. 28, 2015
Banking and Thrift [Abstract]
17. INTEREST EXPENSE	Interest expense table as follows:
		Three Months Ended		Three Months Ended
		February 28,		February 28,
		2014		2015
	Interest accrued on promissory notes and term loan	$	46,002	$	44,901
	Interest paid on short-term loan (Note 6)		43,718		22,158
	Interest paid on vendor payables		9,008		527
	Financing fees		3,306		2,616
			102,035		70,202
	Interest income		143		-
	Total expense	$	101,892	$	70,202

18_TECHNOLOGY_LICENSING_AGREEM

18. TECHNOLOGY LICENSING AGREEMENT	3 Months Ended
	Feb. 28, 2015
Technology Licensing Agreement
18. TECHNOLOGY LICENSING AGREEMENT	On January 19, 2015, the Company signed a Technology Licensing Agreement with a U.S. based entity (the “Licensee”).  The Agreement provides for the Licensee to receive a 99 year non-exclusive license to use Methes’ design and software for a 3,000 liter per hour biodiesel processor to manufacture biodiesel processors for its own projects in the United States. The Agreement provides for the Company to receive a $4 million upfront cash payment, which was originally due on February 20, 2015, and will be entitled to an additional $100,000 for each of the first 40 units manufactured and installed by the Licensee. The Company provided an extension to the initial payment date to allow the Licensee to finalize a pending transaction.  As at February 28, 2015, though they express continuing interest in the transaction with the Company, they still have not finalized their other pending transaction.

19_SUBSEQUENT_EVENT

19. SUBSEQUENT EVENT	3 Months Ended
	Feb. 28, 2015
Subsequent Events [Abstract]
19. SUBSEQUENT EVENT	On March 25, 2015, the Company entered into an agreement with a Canadian purchaser for the sale of the Denami 600 biodiesel processor located at its Mississauga facility and a PP-MEC pre-treatment system and received an initial payment of $199,950 (CDN$250,000) from the purchaser. The agreement provides for the payment of the purchase price over five installments, commencing on the date of the agreement. The additional scheduled payments are due upon shipment and installation of the equipment at the purchaser’s facility.

2_SUMMARY_OF_SIGNIFICANT_ACCOU1

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	3 Months Ended
	Feb. 28, 2015
Accounting Policies [Abstract]
Basis of Consolidation	The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries Methes Canada and Methes USA. All significant inter-company transactions and balances have been eliminated.
Shipping and Handling Costs	The Company accounts for shipping and handling fees in accordance with FASB ASC 705 "Cost of Sales and Services". Shipping and handling costs for the three months ended February 28, 2014 and February 28, 2015 were $15,570 and $17,881, respectively. Costs related to raw materials purchased, are included in inventory or cost of goods sold, as appropriate. While amounts charged to customers for shipping product are included in revenues, the related outbound freight costs are included in expenses as incurred.
Income Taxes and Uncertain Tax Positions	The Company accounts for income taxes under ASC 740 Accounting for Income Taxes. Under ASC 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the periods in which those temporary differences are expected to be recovered or settled. Under ASC 740, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. ASC 740-10-05, Accounting for Uncertainty in Income Taxes, prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return.
	For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities.
	The amount recognized is measured as the largest amount of benefit that is greater than 50 percent likely of being realized upon ultimate settlement. Potential tax benefits from net operating losses and foreign tax credit carry forwards are not recognized by the Company until their realization is more likely than not. The Company assesses the validity of conclusions regarding uncertain tax positions on a quarterly basis to determine if facts or circumstances have arisen that might cause the Company to change their judgment regarding the likelihood of a tax position's sustainability under audit. The Company has determined that there were no material uncertain tax positions as at November 30, 2014 and February 28, 2015.
Per Share Data	Basic earnings per share ("EPS") is determined by dividing net earnings available to common stockholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. In computing diluted EPS, the average number of shares of Common Stock outstanding is increased by Common Stock options and warrants outstanding if the exercise prices were lower than the average market price of Common Stocks using the treasury stock method. Diluted earnings per share exclude all potentially dilutive shares if their effect is anti-dilutive. Potentially dilutive shares include 3,923,149 warrants, 365,931 Common Stock options and 260,782 shares of Preferred Stock issued and outstanding as at February 28, 2014 and 4,073,149 warrants, 426,819 Common Stock options and 111,822 shares of Preferred Stock issued and outstanding as at February 28, 2015. All outstanding warrants, preferred shares and options have an anti-dilutive effect on the loss per share and are therefore excluded from the determination of the diluted loss per share calculation for the three months ended February 28, 2014.
New Accounting Pronouncements	On May 28, 2014, the FASB issued a new financial accounting standard on revenue from contracts with customers, Update No. 2014-09, Revenue from Contracts with Customers (Topic 606). The standard outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance. The accounting standard is effective for annual reporting periods (including interim reporting periods within those periods) beginning after December 15, 2017. Early adoption is not permitted. The Company is currently evaluating the impact of this accounting standard.
	On August 27, 2014, the FASB issued a new financial accounting standard on going concern, Update 2014-15, Presentation of Financial Statements - Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern. The standard provides guidance about management’s responsibility to evaluate whether there is substantial doubt about the organization’s ability to continue as a going concern. The amendments in this Update apply to all companies. They become effective in the annual period ending after December 15, 2016, with early application permitted. The Company is currently evaluating the impact of this accounting standard.
	On April 7, 2015, the FASB issued Accounting Standards Update (ASU) No. 2015-03, Interest - Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs. The amendments in this ASU require that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts and the accounting for debt issue costs under IFRS. The recognition and measurement guidance for debt issuance costs are not affected by the amendments in this ASU. The amendments in this Update apply to all companies. They become effective for public business entities in the annual period ending after December 15, 2015, and interim periods within those fiscal years, with early application permitted. The Company is currently evaluating the impact of this accounting standard.
	All other recent pronouncements issued by the FASB or other authoritative standards groups with future effective dates are either not applicable or are not expected to be significant to the condensed consolidated financial statements of the Company.

3_INVENTORIES_Tables

3. INVENTORIES (Tables)	3 Months Ended
	Feb. 28, 2015
Inventory Disclosure [Abstract]
Schedule of Inventories		As at		As at
		November 30,		February 28,
		2014		2015
	Raw materials	$	199,669	$	207,217
	Finished goods Finished goods		199,664		196,184
	Equipment		11,366		11,366
		$	410,699	$	414,767

4_PROPERTY_PLANT_AND_EQUIPMENT1

4. PROPERTY, PLANT AND EQUIPMENT (Tables)	3 Months Ended
	Feb. 28, 2015
Property, Plant and Equipment [Abstract]
Schedule of Property, Plant and Equipment		As at February 28, 2015						As at
								November 30,
								2014
		Cost		Accumulated		Net Book		Net Book
				Depreciation		Value		Value
	Sombra site:
	Land	$	409,134	$	—	$	409,134	$	409,134
	Building		2,944,356		333,919		2,610,437		2,628,838
	Equipment		775,865		519,479		256,386		283,201
	Equipment - Denami 3000		4,254,995		401,588		3,853,407		3,895,956
	Computer equipment		11,835		11,470		365		937
	Vehicle		11,622		1,744		9,878		10,169
	Mississauga site:
	Computer equipment		23,464		23,464		—		1
	Leasehold improvements		102,201		68,600		33,601		36,200
	Equipment and fixtures		255,463		210,051		45,412		51,721
	Equipment - Denami 600 (note 19)		720,042		197,654		522,388		529,588
		$	9,508,977	$	1,767,969	$	7,741,008	$	7,845,745

5_PAYABLE_TO_RELATED_PARTY_Tab

5. PAYABLE TO RELATED PARTY (Tables)	3 Months Ended
	Feb. 28, 2015
Payable To Related Party Tables
Schedule of Payables to related parties		As at		As at
		November 30,		February 28,
		2014		2015
	Michel G. Laporte (stockholder and Director)	$	81,382	$	82,982

6_SHORTTERM_LOAN_Tables

6. SHORT-TERM LOAN (Tables)	3 Months Ended
	Feb. 28, 2015
Short-term Loan Tables
Short-term loan		As at		Interest Accrued		Repayments		Foreign Exchange Adjustments		As at
		November 30,								February 28,
		2014								2015
	Term loan (July 2013)	$	1,180,035	$	—	$	—	$	-100,305	$	1,079,730

10_STOCKHOLDERS_EQUITY_Tables

10. STOCKHOLDERS' EQUITY (Tables)	3 Months Ended
	Feb. 28, 2015
Stockholders Equity Tables
Common stock		No. of Shares			Price per Share
	Common Stock
	Balance as at November 30, 2013		7,231,417
	Issuance of shares under private placement		1,081,161		$	2
	Issuance of shares under public offering		2,800,000		$	2
	Issuance of shares upon conversion of Preferred Stocks units		148,960		$	2.26
	Issuance of shares upon conversion of accrued dividends on Preferred Stocks units		7,205		$	2.26
	Issuance of shares for cash		16,129		See below
	Issuance of shares for services		183,871		See below
	Issuance of shares for loan settlement		34,688		$	3.69
	Issuance of shares upon conversion of Placement Agent Warrant		7,000			2
	Balance as at November 30, 2014 and February 28, 2015		11,510,431
Stock warrant table		Grant Date		Exercise Period	No of Warrants		Exercise Price per share		Fair Value of Broker Warrants
	Balance as at November 30, 2013					2,678,872
	Common Stock Warrants issued – Private Placement	Dec. 20, 2013		5 years from grant date		1,081,161	$	4
	Placement Agent Warrant – Private Placement	Dec. 20 2013		5 years from grant date		108,116	$	2	$	257,553
	Placement Agent Warrant – Private Placement (November 27, 2013)	Dec. 20 2013		5 years from grant date		5,000	$	2	$	6,403
	Common Stock Warrant issued-accredited investor	Jan. 10, 2014		5 years from grant date		50,000	$	4
	Placement Agent Warrant exercise					-7,000	$	2
	Common Stock Warrant issued upon exercise of Placement Agent Warrant	May 9 and 14, 2014		Dec. 20, 2018		7,000	$	4
	Balance as at November 30, 2014					3,923,149
	Common Stock Warrant issued (note 6)	18-Dec-14		5 years from grant date		150,000	$	0.95
	Balance as at February 28, 2015					4,073,149

11_STOCKBASED_COMPENSATION_Tab

11. STOCK-BASED COMPENSATION (Tables)	3 Months Ended
	Feb. 28, 2015
2012 Option Plan
Stock option activities	Outstanding as at November 30, 2013 and February 28, 2014		100,000
	Granted		—
	Exercised		—
	Cancelled/forfeited		—
	Outstanding as of November 30, 2014 and February 28, 2015		100,000
2008 Directors, Officers and Employees Stock Option Plan
Stock option activities		Number of options
	Outstanding as of November 30, 2013 and February 28, 2014		365,931
	Granted		—
	Exercised		—
	Cancelled/forfeited		-33,897
	Outstanding as of November 30, 2014		332,034
	Granted		—
	Exercised		—
	Cancelled/forfeited		-5,215
	Outstanding as of February 28, 2015		326,819

13_FAIR_VALUE_MEASUREMENTS_CON1

13. FAIR VALUE MEASUREMENTS, CONCENTRATIONS AND RISK (Tables)	3 Months Ended
	Feb. 28, 2015
Fair Value Measurements Concentrations And Risk Tables
Schedule of exchange differences		CDN$		USD$ Historical		USD –February 28, 2015
	Note 6: Term loan (“July 2013”) - Principal	$	1,350,000	$	1,299,915	$	1,079,730
	Note 15: Canadian Incentive - Sombra facility - Total Incentive per Agreement		5,000,000	NA			3,999,000

14_COMMITMENTS_Tables

14. COMMITMENTS (Tables)	3 Months Ended
	Feb. 28, 2015
Commitments and Contingencies Disclosure [Abstract]
Schedule of Annual Minimum Rent			Annual
			Minimum Rent
	2015		$	86,953
	2016		$	115,937
	2017		$	115,937
	2018		$	9,661
Schedule of lease agreements		Start Date		End Date	Term
	Four railcars at $3,100 per month	1-Aug-13		31-Jul-18	60 months
	Four railcars at $3,100 per month	1-Apr-13		31-Mar-18	60 months
	Four railcars at $ 3,600 per month	1-Jul-13		30-Jun-18	60 months
	Four railcars at $3,140  per month	1-Dec-11		30-Nov-16	60 months
	One railcar at $575 per month	1-Jan-12		31-Dec-16	60 months
	One railcar at $575 per month	1-May-12		30-Jun-15	36 months
Schedule of annual minimum rental payments			Annual
			Minimum Rent
	2015		$	123,935
	2016		$	162,180
	2017		$	118,175
	2018		$	62,400

16_SEGMENT_INFORMATION_Tables

16. SEGMENT INFORMATION (Tables)	3 Months Ended
	Feb. 28, 2015
Segment Reporting [Abstract]
Schedule of Revenue Geographically		Three Months Ended February 28,		Three Months Ended February 28,
		2014		2015
	Revenue
	United States	$	288,978	$	843,303
	Canada		89,501		41,016
		$	378,479	$	884,319

17_INTEREST_EXPENSE_Tables

17. INTEREST EXPENSE (Tables)	3 Months Ended
	Feb. 28, 2015
Banking and Thrift [Abstract]
Interest Expense Table		Three Months Ended		Three Months Ended
		February 28,		February 28,
		2014		2015
	Interest accrued on promissory notes and term loan	$	46,002	$	44,901
	Interest paid on short-term loan (Note 6)		43,718		22,158
	Interest paid on vendor payables		9,008		527
	Financing fees		3,306		2,616
			102,035		70,202
	Interest income		143		-
	Total expense	$	101,892	$	70,202

1_NATURE_OF_THE_BUSINESS_AND_G1

1. NATURE OF THE BUSINESS AND GOING CONCERN (Details Narrative) (USD $)	3 Months Ended		12 Months Ended
	Feb. 28, 2015	Feb. 28, 2014	Nov. 30, 2014
Nature Of Business And Going Concern Details Narrative
Working capital deficiency	$1,201,291
Income earned	55,940	-1,481,441	-6,306,476
Net cash used in operating activities	38,296	-697,254
Accumulated deficit	($22,159,475)		($22,215,415)

2_SUMMARY_OF_SIGNIFICANT_ACCOU2

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) (USD $)	3 Months Ended
	Feb. 28, 2015	Feb. 28, 2014
Shipping and handling costs	$15,570	$17,881
Warrants
Shipping and handling costs	4,073,149
Anti-dilutive securities excluded from earnings calculations		3,923,149
Stock Options
Shipping and handling costs	426,819
Anti-dilutive securities excluded from earnings calculations		365,931
Preferred Stock
Shipping and handling costs	$111,822
Anti-dilutive securities excluded from earnings calculations		260,782

3_INVENTORIES_Details

3. INVENTORIES (Details) (USD $)	Feb. 28, 2015	Nov. 30, 2014
Inventories Details
Raw materials	$207,217	$199,669
Finished goods	196,184	199,664
Equipment	11,366	11,366
Inventory, Total	$414,767	$410,699

4_PROPERTY_PLANT_AND_EQUIPMENT2

4. PROPERTY, PLANT AND EQUIPMENT (Details) (USD $)	Feb. 28, 2015	Nov. 30, 2014
Cost	$9,508,977
Accumulated Depreciation	1,767,969
Property Plant and Equipment, Net	7,741,008	7,845,745
Sombra site | Land
Cost	409,134
Accumulated Depreciation
Property Plant and Equipment, Net	409,134	409,134
Sombra site | Building
Cost	2,944,356
Accumulated Depreciation	333,919
Property Plant and Equipment, Net	2,610,437	2,628,838
Sombra site | Equipment
Cost	775,865
Accumulated Depreciation	519,479
Property Plant and Equipment, Net	256,386	283,201
Sombra site | Equipment - Denami 3000
Cost	4,254,995
Accumulated Depreciation	401,588
Property Plant and Equipment, Net	3,853,407	3,895,956
Sombra site | Computer Equipment
Cost	11,835
Accumulated Depreciation	11,470
Property Plant and Equipment, Net	365	937
Sombra site | Vehicle
Cost	11,622
Accumulated Depreciation	1,744
Property Plant and Equipment, Net	9,878	10,169
Mississauga site | Computer Equipment
Cost	23,464
Accumulated Depreciation	23,464
Property Plant and Equipment, Net		1
Mississauga site | Leasehold Improvements
Cost	102,201
Accumulated Depreciation	68,600
Property Plant and Equipment, Net	33,601	36,200
Mississauga site | Equipment and fixtures
Cost	255,463
Accumulated Depreciation	210,051
Property Plant and Equipment, Net	45,412	51,721
Mississauga site | Equipment - Denami 600
Cost	720,042
Accumulated Depreciation	197,654
Property Plant and Equipment, Net	$522,388	$529,588

4_PROPERTY_PLANT_AND_EQUIPMENT3

4. PROPERTY, PLANT AND EQUIPMENT (Details Narrative) (USD $)	3 Months Ended
	Feb. 28, 2015	Feb. 28, 2014
Property Plant And Equipment Details Narrative
Depreciation Expense	$104,741	$105,778

5_PAYABLE_TO_RELATED_PARTY_Det

5. PAYABLE TO RELATED PARTY (Details) (USD $)	Feb. 28, 2015	Nov. 30, 2014
Payable To Related Party Details
Michel G. Laporte (stockholder and Director)	$82,982	$81,382

5_PAYABLE_TO_RELATED_PARTY_Det1

5. PAYABLE TO RELATED PARTY (Details Narrative) (USD $)	3 Months Ended
	Feb. 28, 2015	Feb. 28, 2014
Payable To Related Party Details Narrative
Interest Expense-Related Party	$1,600	$0

6_SHORTTERM_LOANS_Details

6. SHORT-TERM LOANS (Details) (USD $)	3 Months Ended
	Feb. 28, 2015	Nov. 30, 2014
Beginning Balance		$1,180,035
Ending Balance	1,079,730	1,180,035
Term loan (July 2013)
Beginning Balance	1,180,035
Interest Accrued
Repayments
Foreign Exchange Adjustments	-100,305
Ending Balance	$1,079,730

6_SHORTTERM_LOANS_Details_Narr

6. SHORT-TERM LOANS (Details Narrative) (USD $)	3 Months Ended
	Feb. 28, 2015	Feb. 28, 2014
Debt Disclosure [Abstract]
Interest expense	$22,158	$43,718

7_PAYABLE_TO_RELATED_PARTY_ONE1

7. PAYABLE TO RELATED PARTY ONE (Details Narrative) (USD $)	3 Months Ended
	Feb. 28, 2015	Feb. 28, 2014
Notes to Financial Statements
Principal amount outstanding	$674,640	$663,000
Accrued interest	122,731	109,270
Interest expense	$13,461	$13,260

8_TERM_LOAN_Details_Narrative

8. TERM LOAN (Details Narrative) (USD $)	3 Months Ended
	Feb. 28, 2015	Feb. 28, 2014
Debt Disclosure [Abstract]
Principal amount outstanding	$1,492,000	$1,492,000
Accrued interest	375,028	345,188
Interest expense	$29,840	$26,858

9_CREDIT_FACILITY_Details_Narr

9. CREDIT FACILITY (Details Narrative) (USD $)	3 Months Ended
	Feb. 28, 2015	Feb. 28, 2014
Notes to Financial Statements
Credit facility realized losses	$0	$0

12_STOCKHOLDERS_EQUITY_Details

12. STOCKHOLDERS' EQUITY (Details) (USD $)	3 Months Ended
	Feb. 28, 2015
Beginning Balance, Shares	7,231,417
Ending Balance, Shares	11,510,431
Private Placement
Stock issued	1,081,161
Issued, price per share	2
Public Offering
Stock issued	2,800,000
Issued, price per share	2
Conversion of Preferred Stocks units
Stock issued	148,960
Issued, price per share	2.26
Conversion of accrued dividends on Preferred Stocks units
Stock issued	7,205
Issued, price per share	2.26
Issuance of shares for cash
Stock issued	16,129
Issued, price per share
Issuance of shares for services
Stock issued	183,871
Issued, price per share
Issuance of shares for loan settlement
Stock issued	34,688
Issued, price per share	3.69
Issuance of shares upon conversion of Placement Agent Warrant
Stock issued	7,000
Issued, price per share	2

12_STOCKHOLDERS_EQUITY_Details1

12. STOCKHOLDERS' EQUITY (Details 1) (USD $)	3 Months Ended	12 Months Ended
	Feb. 28, 2015	Nov. 30, 2014
Balance beginning of period	3,923,149	2,678,872
Balance end of period	4,073,149	3,923,149
Common Stock Warrants issued Private Placement
Grant Date		Dec. 20, 2013
Exercise Period		5 years
Number of Warrants		1,081,161
Exercise Price per share		4
Placement Agent Warrant Private Placement
Grant Date		Dec. 20 2013
Exercise Period		5 years
Number of Warrants		108,116
Exercise Price per share		2
Fair Value of Broker Warrants		257,553
Placement Agent Warrant Private Placement (November 27, 2013)
Grant Date		Dec. 20 2013
Exercise Period		5 years
Number of Warrants		5,000
Exercise Price per share		2
Fair Value of Broker Warrants		6,403
Common Stock Warrant issued-accredited investor
Grant Date		Jan. 10, 2014
Exercise Period		5 years
Number of Warrants		50,000
Exercise Price per share		4
Placement Agent Warrant exercise
Number of Warrants		-7,000
Exercise Price per share		2
Common Stock Warrant issued upon exercise of Placement Agent Warrant
Grant Date		B May 9 and 14, 2014
Exercise Period Date		Dec. 20, 2018
Number of Warrants		7,000
Exercise Price per share		4
Common Stock Warrant issued
Grant Date	18-Dec-14
Exercise Period	5 years
Number of Warrants	150,000
Exercise Price per share	0.95

10_STOCKHOLDERS_EQUITY_Details

10. STOCKHOLDERS' EQUITY (Details Narrative) (USD $)	3 Months Ended	12 Months Ended
	Feb. 28, 2015	Nov. 30, 2014
Equity [Abstract]
Preferred stock par value	$0.00	$0.00
Preferred stock shares authorized	10,000,000	10,000,000
Preferred stock shares issued	111,822	111,822
Preferred stock shares outstanding	111,822	111,822
Common stock, par value	$0.00	$0.00
Common stock, shares authorized	75,000,000	75,000,000
Common stock, shares issued	11,510,431	11,510,431
Common stock, shares outstanding	11,510,431	11,510,431
Accumulated dividends on preferred stock	$48,548	$23,004

11_STOCKBASED_COMPENSATION_Det

11. STOCK-BASED COMPENSATION (Details )	3 Months Ended	12 Months Ended
	Feb. 28, 2015	Nov. 30, 2014
2008 Option Plan
Number of Options Outstanding, Beginning	332,034	365,931
Number of Options Granted
Number of Options Exercised
Number of Options Canceled/Forfeited	-5,215	-33,897
Number of Options, Ending	326,819	332,034
2012 Option Plan
Number of Options Outstanding, Beginning	100,000	100,000
Number of Options Granted
Number of Options Exercised
Number of Options Canceled/Forfeited
Number of Options, Ending	100,000	100,000

11_STOCKBASED_COMPENSATION_Det1

11. STOCK-BASED COMPENSATION (Details Narrative) (USD $)	3 Months Ended
	Feb. 28, 2015	Feb. 28, 2014	Nov. 30, 2014
Stock-based compensation	$1,009	$48,898
2008 Option Plan
Stock-based compensation	1,009	4,872
Options vested and exercisable	324,319		328,284
Fair value of the options granted to employees	1,136,616		1,172,498
Unrecognized portion options granted to employees	892		1,901
Recognized period	9 months	1 year
2012 Option Plan
Stock-based compensation		44,026
Fair value of the options granted to employees	$292,174

12_OTHER_REVENUE_Details_Narra

12 - OTHER REVENUE (Details Narrative) (USD $)	3 Months Ended
	Feb. 28, 2015	Feb. 28, 2014
Other Revenue
Others	$843,338	$15,440
Accounts receivable To related party	$513,839

13_FAIR_VALUE_MEASUREMENTS_CON2

13. FAIR VALUE MEASUREMENTS, CONCENTRATIONS AND RISK (Details) (USD $)	3 Months Ended
	Feb. 28, 2015
Term loan	$1,079,730
Term loan - Partial payment	3,999,000
CDN
Term loan	1,350,000
Term loan - Partial payment	5,000,000
USD Historical
Term loan	1,299,915
Term loan - Partial payment

13_FAIR_VALUE_MEASUREMENTS_CON3

13. FAIR VALUE MEASUREMENTS, CONCENTRATIONS AND RISK (Details Narrative) (USD $)	3 Months Ended
	Feb. 28, 2015	Feb. 28, 2014	Nov. 30, 2014
Allowance of doubtful accounts	$30,000		$30,000
Selling general and administrative expenses	126,800	79,786
Major Customer One | Revenue [Member]
Concentrations risk	69.00%	71.00%
Major Customer One | Accounts Receivable [Member]
Accounts receivable	280,541		24,306
Major Customer Two | Revenue [Member]
Concentrations risk	18.00%	9.00%
Major Customer Two | Accounts Receivable [Member]
Accounts receivable	185,486		24,194
Major Vendor
Purchases from vendor	0	0
Accounts payable to vendor	6,837		0
Major Vendor Two
Accounts payable to vendor	0		0
Major Vendor Three
Accounts payable to vendor	$0		$6,398

14_COMMITMENTS_Details

14. COMMITMENTS (Details) (USD $)	Feb. 28, 2015
Mississauga Facility
2015	$86,953
2016	115,937
2017	115,937
2018	9,661
Sombra Facility
2015	123,935
2016	162,180
2017	118,175
2018	$62,400

14_COMMITMENTS_Details_1

14. COMMITMENTS (Details 1)	3 Months Ended
	Feb. 28, 2015
Agreement 1
Start Date	1-Aug-13
End Date	31-Jul-18
Term	60 months
Agreement 2
Start Date	1-Apr-13
End Date	31-Mar-18
Term	60 months
Agreement 3
Start Date	1-Jul-13
End Date	30-Jun-18
Term	60 months
Agreement 4
Start Date	1-Dec-11
End Date	30-Nov-16
Term	60 months
Agreement 5
Start Date	1-Jan-12
End Date	31-Dec-16
Term	60 months
Agreement 6
Start Date	1-May-12
End Date	30-Jun-15
Term	36 months

16_CONTRIBUTION_AGREEMENTS_WIT

16. CONTRIBUTION AGREEMENTS WITH MINISTER OF NATURAL RESOURCES OF CANADA (Details Narrative) (USD $)	3 Months Ended		68 Months Ended
	Feb. 28, 2015	Feb. 28, 2014	Feb. 28, 2015	Nov. 30, 2014
Sombra site
Incentives	$1,637	$13,035	$904,473
Received incentives			902,836
Accounts receivable	1,637		1,637	147,776
Mississauga site
Incentives	$1,458,286

16_SEGMENT_INFORMATION_Details

16. SEGMENT INFORMATION (Details) (USD $)	3 Months Ended
	Feb. 28, 2015	Feb. 28, 2014
Revenue
Revenue	$884,319	$378,479
United States
Revenue
Revenue	843,303	288,978
Canada
Revenue
Revenue	$41,016	$89,501

16_SEGMENT_INFORMATION_Details1

16. SEGMENT INFORMATION (Details Narrative) (USD $)	Feb. 28, 2015	Nov. 30, 2014
Segment Information Details Narrative
Assets and operating facilities, other than cash and cash equivalents balances	$24,314	$4,943

17_INTEREST_EXPENSE_Details

17. INTEREST EXPENSE (Details) (USD $)	3 Months Ended
	Feb. 28, 2015	Feb. 28, 2014
Interest expense	$70,202	$102,035
Interest income	0	143
Total expense	70,202	101,892
Promissory notes [Member]
Interest expense	44,901	46,002
Short-term loan [Member]
Interest expense	22,158	43,718
Vendor payables [Member]
Interest expense	527	9,008
Financing fees [Member]
Interest expense	$2,616	$3,306